Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients

Barbui, T.; De Stefano, V.; Carobbio, A.; Iurlo, A.; Alvarez-Larran, A.; Cuevas, B.; Ferrer Marin, F.; Vannucchi, A.M.; Palandri, F.; Harrison, C.; Sibai, H.; Griesshammer, M.; Bonifacio, M.; Elli, E.M.; Trotti, C.; Koschmieder, S.; Carli, G.; Benevolo, G.; Ianotto, J.-.; Goel, S.; Falanga, A.; Betti, S.; Cattaneo, D.; Arellano-Rodrigo, E.; Mannelli, L.; Vianelli, N.; Doyle, A.; Gupta, V.; Wille, K.; Tremblay, D.; Mascarenhas, J.

doi:10.1038/s41375-021-01279-1

Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients / T. Barbui, V. De Stefano, A. Carobbio, A. Iurlo, A. Alvarez-Larran, B. Cuevas, F. Ferrer Marin, A.M. Vannucchi, F. Palandri, C. Harrison, H. Sibai, M. Griesshammer, M. Bonifacio, E.M. Elli, C. Trotti, S. Koschmieder, G. Carli, G. Benevolo, J.-. Ianotto, S. Goel, A. Falanga, S. Betti, D. Cattaneo, E. Arellano-Rodrigo, L. Mannelli, N. Vianelli, A. Doyle, V. Gupta, K. Wille, D. Tremblay, J. Mascarenhas. - In: LEUKEMIA. - ISSN 0887-6924. - 35:10(2021 Oct), pp. 2989-2993. [10.1038/s41375-021-01279-1]